Japan· JP-2634706M1020
クロラムフェニコール
A chloramphenicol product containing クロラムフェニコール, registered in Japan by アルフレッサファーマ, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Chloramphenicol is registered in 6 of 19 countries.
Countries holding a registration under ATC J01BA01 (chloramphenicol), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 3 of them publish a price we can compare per daily dose
Chloramphenicol · ATC J01BA01
6 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Japan
- Norwayprice
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- クロラムフェニコール
- Manufacturer
- アルフレッサファーマ
- Country
- Japan (JP)
- ATC code
- J01BA01
- ATC class
- Chloramphenicol
- Defined daily dose
- 3 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
571 interactions on record for chloramphenicol.
Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Chloramphenicol · interactions on record
571 records
- 42 severe
- 445 moderate
- 23 minor
- 61 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LonafarnibA16AX20severe
- GuanfacineC02AC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01BA01
Chloramphenicol, as other registers publish it.
- FinlandChloramexAlpharma ApS
- FinlandChloramphenORION
- FinlandChloramphen VfOrion Corporation Orion Pharma
- FinlandChloramphen Vf PedOrion Corporation Orion Pharma
- United KingdomChloramphenicol 1g powder for solution for injection vialsAlliance Healthcare (Distribution) Ltd
- United KingdomChloramphenicol 1g powder for solution for injection vialsA A H Pharmaceuticals Ltd
- United KingdomChloramphenicol 1g powder for solution for injection vialsEramol (UK) Ltd
- United KingdomChloramphenicol 1g powder for solution for injection vialsEssential Pharma Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5b8e2ed-b52d-457e-b924-23059655aef0 GET /v1/drugs/c5b8e2ed-b52d-457e-b924-23059655aef0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２０ｍｇ１ｇ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2634706M1020",
"category": "外用薬",
"price_yen": 8.2,
"generic_name": "クロラムフェニコール",
"product_name_jp": null,
"therapeutic_class": "2634",
"transitional_expiry": null
}See everything about chloramphenicol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.